AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Black, M. R.
Right arrow Articles by Welke, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Black, M. R.
Right arrow Articles by Welke, R.
Agricola
Right arrow Articles by Black, M. R.
Right arrow Articles by Welke, R.

American Journal of Clinical Nutrition, Vol 47, 970-975, Copyright © 1988 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Zinc supplements and serum lipids in young adult white males

MR Black, DM Medeiros, E Brunett and R Welke
Department of Home Economics, University of Wyoming, Laramie 82071.

A 12-wk double-blind study was conducted to determine the effect of oral zinc supplementation upon serum total cholesterol, lipoprotein- cholesterol fractions, and serum triglycerides in white males. The subjects were randomly assigned to one of three treatment groups and consumed either a placebo tablet (n = 9), 50 mg Zn/d (n = 13), or 75 mg Zn/d (n = 9) as Zn gluconate. Serum total cholesterol, low-density- lipoprotein (LDL) cholesterol, very-low-density-lipoprotein (VLDL) cholesterol, and triglycerides were not affected by Zn supplements. However, serum high-density-lipoprotein (HDL)-cholesterol levels in subjects assigned to the 75 mg Zn/d group were significantly lower at weeks 6 and 12 than those for the placebo group and lower at weeks 6, 8, and 12 than at baseline; subjects assigned to the 50 mg Zn/d group had lower serum HDL-cholesterol levels at week 12 than did the placebo group and lower at week 12 than at base line.


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
N. M Lowe, K. Fekete, and T. Decsi
Methods of assessment of zinc status in humans: a systematic review
Am. J. Clinical Nutrition, June 1, 2009; 89(6): 2040S - 2051S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Shen, R. MacDonald, D. Bruemmer, A. Stromberg, A. Daugherty, X.-a. Li, M. Toborek, and B. Hennig
Zinc Deficiency Alters Lipid Metabolism in LDL Receptor Deficient Mice Treated with Rosiglitazone
J. Nutr., November 1, 2007; 137(11): 2339 - 2345.
[Abstract] [Full Text] [PDF]


Home page
Toxicol Ind HealthHome page
N. Roney, M. Osier, S. J. Paikoff, C. V. Smith, M. Williams, and C. T. De Rosa
ATSDR evaluation of potential for human exposure to zinc
Toxicology and Industrial Health, June 1, 2007; 23(5-6): 247 - 308.
[Abstract] [PDF]


Home page
J. Am. Coll. Nutr.Home page
S. Hughes and S. Samman
The effect of zinc supplementation in humans on plasma lipids, antioxidant status and thrombogenesis.
J. Am. Coll. Nutr., August 1, 2006; 25(4): 285 - 291.
[Abstract] [Full Text] [PDF]


Home page
Toxicol Ind HealthHome page
N. Roney, M. Osier, S. J. Paikoff, C. V. Smith, M. Williams, and C. T. De Rosa
ATSDR evaluation of the health effects of zinc and relevance to public health
Toxicology and Industrial Health, January 1, 2006; 22(10): 423 - 493.
[Abstract] [PDF]


Home page
J. Nutr.Home page
G. Reiterer, R. MacDonald, J. D. Browning, J. Morrow, S. V. Matveev, A. Daugherty, E. Smart, M. Toborek, and B. Hennig
Zinc Deficiency Increases Plasma Lipids and Atherosclerotic Markers in LDL-Receptor-Deficient Mice
J. Nutr., September 1, 2005; 135(9): 2114 - 2118.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
J. A. Mares, T. L. La Rowe, and B. A. Blodi
Doctor, What Vitamins Should I Take for My Eyes?
Arch Ophthalmol, April 1, 2004; 122(4): 628 - 635.
[Full Text] [PDF]


Home page
J. Nutr.Home page
Abstract Section: 11th International Symposium on Trace Elements in Man and Animals Abstracts
J. Nutr., May 1, 2003; 133(5): 203E - 282.
[Full Text] [PDF]


Home page
J. Nutr.Home page
The Age-Related Eye Disease Study Research Group
The Effect of Five-Year Zinc Supplementation on Serum Zinc, Serum Cholesterol and Hematocrit in Persons Randomly Assigned to Treatment Group in the Age-Related Eye Disease Study: AREDS Report No. 7
J. Nutr., April 1, 2002; 132(4): 697 - 702.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A.-R. E. D. S. R. Group
The Age-Related Eye Disease Study: A Clinical Trial of Zinc and Antioxidants--Age-Related Eye Disease Study Report No. 2
J. Nutr., May 1, 2000; 130(5): 1516S - 1519.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by The American Society for Nutrition